At a glance
ClinicalIndex Comparison RecordN/ACompleted· 318 enrolled
Drug / intervention
Presillion stentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter Postmarket Surveillance Registry Evaluating the Performance and Long Term Safety of the Presillion Stent in de Novo Native Coronary Artery Lesions. Iberian Registry
In Brief
An observational study evaluating Presillion stent for Coronary Arteriosclerosis. Completed, enrolled 318 participants across 13 sites in 2 countries.
Detailed Summary
The purpose of this study is: To evaluate the safety and performance of the Presillion stent in routine clinical practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Arteriosclerosis
CountriesPortugal, Spain
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2009
First PostedAug 2009
Primary CompletionApr 2011
Study CompletionMay 2011
TodayJul 2026
First PostedAug 28, 2009
Enrollment StartApr 1, 2009
Primary CompletionApr 1, 2011
Study CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 16.8 years ago
Interventions
Presillion stentdevice
Centers will use commercially available Presillion Stents as recommended according to the Instruction For Use (IFU).